77 posters, 5 topics, 469 authors, 212 institutions

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

Posters

1.01

Cell therapy model in hemophilia B by genetically modified keratinocytes by lentiviral vectors to produce human clotting factor IX.

Isaura Gonzalez Ramos, Irving Lara Navarro, Luis Jave Suarez, Juan Marchal Corrales, Antonio Bernad Miana, Ana Jaloma Cruz

Guadalajara University, University Center of health sciences, Guadalajara, Jalisco, MexicoWest Biomedical Research Center of Social Security Mexican Institute, Department of Genetics, Tissue Culture, Guadalajara, Jalisco, Mexico, Guadalajara University, University Center for agricultural biosciences, Guadalajara, Jalisco, Mexico, West Biomedical Research Center of Social Security Mexican Institute, Department of Genetics, Tissue Culture, Guadalajara, Jalisco, Mexico, West Biomedical Research Center of Social Security Mexican Institute, Department of Immunology Guadalajara, Jalisco, Mexico, Department of Anatomy and Embryology Faculty of Medicine, Institute of Biopathology and Regenerative Medicine, Biomedical Research Centre (CIBM), University of Granada, Granada, Spain., Head of Department of Regenerative Cardiology Foundation National Centre for Cardiovascular Research Carlos III, Madrid, Spain., Guadalajara University, University Center of health sciences, Guadalajara, Jalisco, Mexico

Poster Presenter: Isaura González Ramos

1.02

Influence of aPTT reagents on the 1-stage clotting assay activity in human plasma determined for recombinant FIX products

Herbert Gritsch, Stefan Romeder-Finger, Friedrich Scheiflinger, Peter Turecek

Baxter Innovations GmbH, Vienna, Austria

1.03

Does the factor IXa content of factor IX products impact function, safety and efficacy?

Gerald Schrenk, Werner Hoellriegl, Alexandra Schiviz, Hanspeter Rottensteiner, Friedrich Scheiflinger, Hans Peter Schwarz, Peter L. Turecek, Eva-Maria Muchitsch

Baxter Innovations GmbH, Vienna, Austria

The Poster has not been submitted by the Author.

1.04

Association of miR-132 and miR-185 Genes Methylation and their Expression profile with Risk Congenital factor XIII deficiency

Majid Naderi, Akbar Dorgalaleh, Dor Mohammad Kordi-Tamandani, zohreh Rezaei, Shaban Alizadeh, Peyman Eshghi, Shadi Tabibian

Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical Sciences, Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran, Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran, Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

The Poster has not been submitted by the Author.

1.05

Disseminated Intravascular Coagulation a Controversial Clinical Feature in Congenital Factor XIII Deficiency in Southeast of Iran

Majid Naderi, Akbar Dorgalaleh, Shaban Alizadeh, Shadi Tabibian, Marzia Menegatti

Genetic Researcher Center in Non-Communicable Disease, Zahedan University of Medical Sciences, Department of Hematology, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran, A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS, Ca’ Granda Ospedale Maggiore Policlinico, Department of Pathophysiology Transplantation, University of Milan and Luigi Villa Foundation

1.06

Global Development Plan for a Double Virus Inactivated Fibrinogen Concentrate for the Treatment of Congenital Fibrinogen Deficiency

F Peyvandi, B Schwartz, S Knaub, O Hegener

University of Milan, Milan, Italy, Octapharma USA, Inc., Hoboken, USA, Octapharma AG, Lachen, Switzerland

The Poster has not been submitted by the Author.

1.07

Correlation of Genotype and Phenotype in Patients with Rare Bleeding Disorders in Pakistan

Munira Borhany, Helena Handrkova, Andrea Cairo, Naveena Fatima, Hira Fatima, Arshi Naz, Tahir Shamsi, Flora Peyvandi, Hans Peter Kohler

Department of Haemostasis & Thrombosis, National Institute of Blood Disease & Bone Marrow Transplantation (NIBD), Karachi Pakistan., University Clinic of Haematology, Haemostasis Research Laboratory, University Hospital & University of Bern, Bern, Switzerland, U.O.S. Dipartimentale per la Diagnosi e la Terapia delle Coagulopatie, A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione I.R.C.C.S. Cà Granda Ospedale Maggiore Policlinico, Università degli Studi Milano, Italy, Department of Research and Development, National Institute of Blood Disease & Bone Marrow Transplantation (NIBD), Karachi Pakistan.

The Poster has not been submitted by the Author.

1.08

Genotype and Phenotype relationships in 10 Pakistani Unrelated patients with inherited Factor VII deficiency

Munira Borhany, H. Boijout, J.-l. Pellequer, N. Fatima, T. Shamsi, G. Moulis, P. Martinez, J.-F. Schved, M. Blaizot

Department of haemostasis & thrombosis, national institute of blood disease & bone marrow transplantation, Karachi, Pakistan, CHU Montpellier, Département d’hématologie biologique, Hopital Saint-Eloi, Montpellier, France; and Cea, Ibeb, Service de biochimie et toxicologie nucléaire, Bagnols sur Cèze, France, Department of research and development,national institute of blood disease & bone marrow transplantation, karachi, Pakistan

2.02

Defining The Molecular Basis Underlying The Physiological Interaction Between Von Willebrand Factor And Galectins In Normal Plasma

Orla Rawley, Jamie O'Sullivan, Alain Chion, Niamh O'Regan, P. Vince Jenkins, Teresa Brophy, James O'Donnell

Center for HUS prevention, control and management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy for the North Italian HUS Network, Haemostasis Research Group, Institute of Molecular Medicine, St. James's Hospital Campus, Trinity College Dublin, Ireland, Haemostasis Research Group, Institute of Molecular Medicine, St. James’s Hospital, Trinity College Dublin, Ireland.

Pages